EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 364 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $478 | -99.8% | 25 | -99.8% | 0.00% | -100.0% |
Q1 2023 | $246,915 | -50.0% | 12,721 | -58.7% | 0.00% | -50.0% |
Q4 2022 | $494,000 | +32.4% | 30,798 | +29.4% | 0.00% | 0.0% |
Q3 2022 | $373,000 | +136.1% | 23,801 | +214.4% | 0.00% | +100.0% |
Q2 2022 | $158,000 | +338.9% | 7,571 | +371.7% | 0.00% | – |
Q1 2022 | $36,000 | +800.0% | 1,605 | +781.9% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 182 | -17.3% | 0.00% | – |
Q3 2020 | $5,000 | 0.0% | 220 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | +400.0% | 220 | +511.1% | 0.00% | – |
Q4 2018 | $1,000 | – | 36 | +260.0% | 0.00% | – |
Q4 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.92% |